PhD
Dr. Burcu Uner is a researcher and academic specializing in nanoparticle-based targeted drug delivery and preclinical oncology models. With expertise spanning cancer nanomedicine, ocular and mitochondrial drug delivery, and translational in vivo studies, she has contributed to advancements in intracellular targeting and drug formulation strategies. She also possesses strong skills in computational modeling, molecular dynamics, bioinformatics, and advanced imaging techniques. Her international experience includes a postdoctoral fellowship at Washington University School of Medicine, USA, and academic roles in leading Turkish universities.
Guest Editor, MDPI Pharmaceutics (2024–2025)
Editorial Board Member: Oral Drug Delivery – Frontiers, Journal of Research in Pharmacy, Therapeutic Delivery (Future Science Group)
Reviewer for Nature Communications, Scientific Reports, Journal of Controlled Release, among others
Member of AACR, EUFEPS, and NPA
Multikinase inhibition-mediated proliferative vitreoretinopathy therapy by nanoparticles in rabbits. Molecular.
Nanoparticle Formulations for Intracellular Delivery in Colorectal Cancer Therapy.
Kinetic assessment of iontophoretic delivery efficiency of niosomal tetracycline hydrochloride incorporated in electroconductive gel.
Enhanced mitochondrial co-localization of β-escin micelle and pancreatic tumor accumulation relation.
